HGS Fires Round 2 At Genentech Over Lupus Drug IP
Human Genome Sciences on Tuesday continued its assault on Genentech Inc. and cancer center City of Hope, filing its second declaratory judgment suit this year over patents covering the lupus drug...To view the full article, register now.
Already a subscriber? Click here to view full article